Clinical trial
Markers for Breast Cancer
NCT00339248 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00339248 |
|---|---|
| Title | Markers for Breast Cancer |
| Official title | Risk of Breast Cancer and Hyperplastic Conditions in the Breast Cancer Serum Bank in Relation to Inherited Genetic Variants |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 2,632 |
| Start date | Dec 1, 2004 |
| First posted | Jun 21, 2006 |
| Last update posted | Mar 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: